Hangzhou, China

Nanhai He

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nanhai He: Innovator in Tumor Immunotherapy

Introduction

Nanhai He, an accomplished inventor based in Hangzhou, China, has made significant contributions to the field of tumor immunotherapy. With a total of two patents to his name, his work aims to enhance the assessment of agents designed for cancer treatment, showcasing his commitment to innovative research and medical advancement.

Latest Patents

Nanhai He's latest patents include important developments in tumor immunotherapy. The first patent, titled "System and method for screening and assessing agents for tumor immunotherapy," outlines a comprehensive method for effectively screening and evaluating the effects of therapeutic agents. This system assesses target cells, non-target cells, and the infiltration of tumors, contributing to a more systematic understanding of the effectiveness and safety of agents against tumor immune cells.

His second patent, "Construction of fully human antibody yeast display technique," describes a method for creating a yeast display library (YSD). This innovative approach includes constructs, expression vectors, host cells, and methods for use, leading to a library characterized by high transformation efficiency and rich diversity. These advancements are poised to significantly impact cancer therapy.

Career Highlights

Nanhai He is currently employed at Adlai Nortye Biopharma Co., Ltd., where he utilizes his expertise to further research and development in the biopharmaceutical industry. His dedication to innovation in cancer treatment reflects a broader goal of improving patient outcomes and advancing therapeutic techniques in the medical field.

Collaborations

Nanhai He collaborates with esteemed colleagues in his field, including Yang Lu and Donghui Yang. Working alongside these professionals, he continues to push the boundaries of research in tumor immunotherapy, fostering an environment of innovation and shared knowledge.

Conclusion

Nanhai He's contributions to the field of tumor immunotherapy through his patents demonstrate the vital role of inventors in advancing medical science. His innovative methods and collaborative efforts at Adlai Nortye Biopharma Co., Ltd. stand as a testament to the impact that dedicated inventors can have on significant healthcare challenges. As research progresses, Nanhai He's work remains crucial in the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…